The Association for Clinical Oncology (ASCO) submitted a statement to the U.S. Senate Committee on Homeland Security and Government Affairs for a hearing titled, “Drug Shortage Health and National Security Risks: Underlying Causes and Needed Reforms.”
ASCO’s statement highlighted the current drug shortages facing the oncology community and offered specific recommendations to help mitigate them. ASCO’s recommendations focus on improving the resilience of the nation’s health care infrastructure through a range of suggested policy and marketplace changes that would additionally help address drug shortages.
ASCO, along with collaborating organizations, was among the first stakeholder groups to identify drug shortages as a matter of national security. Since then, the Association has regularly worked with lawmakers, federal agencies, and stakeholder organizations to raise awareness of the issue and advance legislation to help reinforce supplies of needed cancer treatments.
Read the full statement.
Visit ASCO in Action for updates on addressing drug shortages and the latest news, advocacy, and analysis on cancer policy.